Comparing surgical methods for endometrial cancer treatment
Official title: Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy
Run by Far Eastern Memorial Hospital · NCT05969405 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study looks at how different types of surgery for endometrial cancer affect women's recovery and outcomes to see which method works best.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years and up |
| Sex | Women only |
| Enrollment | 400 (estimated) |
| Sponsor | Far Eastern Memorial Hospital Academic / other |
| Locations | 1 site (Banqiao, New Taipei) |
| Trial ID | NCT05969405 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women diagnosed with uterine-confined endometrial cancer who have undergone one of the specified surgical methods.
✕Probably not a fit
Patients who did not undergo surgery for endometrial cancer will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the clinical outcomes of women with endometrial cancer who underwent different surgical treatments: robotic-assisted laparoscopy, traditional laparoscopy, and laparotomy. By reviewing medical records from patients treated between January 2008 and November 2022, the study will analyze the effectiveness and prognosis associated with each surgical method. The observational approach allows for a comprehensive assessment of real-world outcomes without direct intervention.
Why it matters
Potential benefit: If successful, this study could help identify the most effective surgical approach for treating endometrial cancer, leading to improved patient outcomes.
How similar studies have gone: Other studies have explored surgical methods for endometrial cancer, but this specific comparison of robotic-assisted versus traditional techniques is less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * womwn who received endometrial cancer surgical from January 01, 2008 to November 30, 2022 were be reviewed. Exclusion Criteria: * Endometrial cancer patients did not undergo surgery.
Where it's running
-
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
Banqiao, New Taipei, Taiwan Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized navigation to support rural and Black women with endometrial cancer
This pilot tests a tailored patient-navigation program to help rural and Black patients with endometrial cancer access care and services.
-
CR-002 study in adults with advanced solid tumors
This trial tests CR-002 as a single therapy to see if it is safe and tolerable in adults with locally advanced or metastatic solid tumors
-
Methylation markers in self-samples to help detect gynecological cancers
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Liquid biopsy screening for early endometrial cancer in regional China
A non-invasive blood test using cell-free DNA is being tested to see if it can detect early endometrial cancer and tell apart benign from malignant uterine lesions.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.